Federated Hermes’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
266,946
+28,073
+12% +$164K ﹤0.01% 1009
2025
Q4
$1.71M Buy
238,873
+105,459
+79% +$750K ﹤0.01% 994
2025
Q3
$1.01M Buy
+133,414
New +$974K ﹤0.01% 1145
2023
Q4
Sell
-482
Closed -$2.34K 2085
2023
Q3
$2.34K Buy
482
+19
+4% +$117 ﹤0.01% 1956
2023
Q2
$2.78K Buy
+463
New +$2.19K ﹤0.01% 1971
2023
Q1
Sell
-506
Closed -$1.31K 2163
2022
Q4
$1.31K Buy
+506
New +$1.49K ﹤0.01% 2039

Other funds holding EVLV

Federated Hermes's EVLV Position: Q1 2026 in Review

Federated Hermes increased its Evolv Technologies (EVLV) stake by 12% in Q1 2026, buying an estimated $164K and bringing the position to 266,946 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Federated Hermes first reported a position in EVLV in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.71M in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Federated Hermes held 266,946 shares of Evolv Technologies worth $1.62M as of Q1 2026.
  • Federated Hermes bought 28,073 Evolv Technologies shares in Q1 2026, an estimated $164K.
  • Evolv Technologies made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1009 holding.
  • Federated Hermes first reported a position in Evolv Technologies in Q4 2022 and has held it in 6 quarters since.
  • Federated Hermes's Evolv Technologies position peaked at $1.71M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.